IMMUNOWAKE
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.
IMMUNOWAKE
Social Links:
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Birmingham, Alabama, United States
Country:
United States
Website Url:
http://www.immunowake.com
Total Employee:
11+
Status:
Active
Total Funding:
23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Employees Featured
Founder
Investors List
Hyfinity Investments
Hyfinity Investments investment in Series A - Immunowake
South China Venture Capital
South China Venture Capital investment in Series A - Immunowake
Lapam Capital
Lapam Capital investment in Series A - Immunowake
HEDA Ventures
HEDA Ventures investment in Series A - Immunowake
Official Site Inspections
http://www.immunowake.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
